What is TetraScience?
TetraScience operates the R&D Data Cloud, a specialized platform designed to address the fragmentation of scientific data within life sciences organizations. By providing a centralized, scalable, and vendor-neutral environment, the company enables seamless interoperability across complex laboratory ecosystems. Its platform is engineered to harmonize data from diverse sources, including lab instruments, electronic lab notebooks, and various informatics applications, thereby creating an actionable data foundation for researchers. This capability is essential for enterprise pharma and biotech firms aiming to leverage advanced analytics and data science to shorten development cycles and improve patient outcomes. As an open platform, TetraScience has cultivated an extensive partner network, positioning itself as the central nervous system for modern, data-driven R&D operations.
How much funding has TetraScience raised?
TetraScience has raised a total of $103M across 3 funding rounds:
Series A
$8M
Series B
$80M
Stock/Share Issuance
$15M
Series A (2019): $8M with participation from Waters, Y Combinator, Underscore VC, First Round Capital, Founder Collective, and Floodgate Capital
Series B (2021): $80M led by Insight Partners and Alkeon Capital Management
Stock/Share Issuance (2026): $15M, investors not publicly disclosed
Key Investors in TetraScience
Insight Partners
A global venture capital and private equity firm that invests in high-growth technology and software companies, providing deep operational support to help portfolio companies scale effectively.
Waters
A leading specialty measurement company that provides analytical instruments and software to improve human health and well-being through scientific insights.
Y Combinator
A premier startup accelerator and venture capital firm that provides early-stage funding and mentorship to high-potential technology companies.
What's next for TetraScience?
With the successful closure of this major strategic investment, TetraScience is well-positioned to accelerate its product roadmap and deepen its penetration into the enterprise life sciences market. The company is expected to focus on enhancing its data-centric capabilities, specifically targeting the integration of AI-driven analytics and expanding its footprint within global CRO and CDMO networks. By fostering a robust innovation feedback loop, TetraScience aims to set the industry standard for scientific data management, ensuring that its clients can derive maximum value from their R&D investments. Future strategic initiatives will likely prioritize the scaling of its cloud infrastructure to support increasingly complex, high-throughput scientific workflows, further cementing its role as an indispensable partner in the pursuit of medical breakthroughs.
See full TetraScience company page
